View in EDS PDF Full Text

Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction.

Saved in:
Bibliographic Details
Title: Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction.
Authors: Israel E; Pulmonary and Critical Care Medicine, Allergy and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Castro M; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA., Ambrose CS; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, CA, USA., Molfino NA; Global Development, Amgen, Thousand Oaks, CA, USA., Martin NL; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Cytel Inc., Waltham, MA, USA., Ponnarambil SS; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Martin N; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; University of Leicester, Leicester, UK.
Source: ERJ open research [ERJ Open Res] 2024 Nov 25; Vol. 10 (6). Date of Electronic Publication: 2024 Nov 25 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39588080
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Israel+E%22">Israel E</searchLink>; Pulmonary and Critical Care Medicine, Allergy and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Castro+M%22">Castro M</searchLink>; Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Ambrose+CS%22">Ambrose CS</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Llanos+JP%22">Llanos JP</searchLink>; Global Medical Affairs, Amgen, Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Molfino+NA%22">Molfino NA</searchLink>; Global Development, Amgen, Thousand Oaks, CA, USA.<br /><searchLink fieldCode="AU" term="%22Martin+NL%22">Martin NL</searchLink>; Biometrics, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.; Cytel Inc., Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ponnarambil+SS%22">Ponnarambil SS</searchLink>; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Martin+N%22">Martin N</searchLink>; Respiratory and Immunology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.; University of Leicester, Leicester, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101671641%22">ERJ open research</searchLink> [ERJ Open Res] 2024 Nov 25; Vol. 10 (6). <i>Date of Electronic Publication: </i>2024 Nov 25 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101671641 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2312-0541 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223120541%22">23120541 </searchLink><i>NLM ISO Abbreviation: </i>ERJ Open Res <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39588080
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/23120541.00164-2024
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Israel E
      – PersonEntity:
          Name:
            NameFull: Castro M
      – PersonEntity:
          Name:
            NameFull: Ambrose CS
      – PersonEntity:
          Name:
            NameFull: Llanos JP
      – PersonEntity:
          Name:
            NameFull: Molfino NA
      – PersonEntity:
          Name:
            NameFull: Martin NL
      – PersonEntity:
          Name:
            NameFull: Ponnarambil SS
      – PersonEntity:
          Name:
            NameFull: Martin N
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 11
              Text: 2024 Nov 25
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2312-0541
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: ERJ open research
              Type: main
ResultId 1